DVAX retracement plotted using recent lows and the high from Aug 2018...figured that would be more than enough on the big picture to see any potential levels of interest. In this case, sure enough, there were. Mainly, the 236 fib line has been an area of higher traffic over the last 3 years. Further, DVAX has yet to establish a substantial support above this...
With all the recent hype surrounding $MRNA coming from delta-variant and booster shots, coupled with a great Q2 report, the stock is now overbought and forming a head and shoulders pattern. Notice the RSI being overbought and MACD forming a cross, too.
On 7/15/2021 Jefferies Financial Group brokerage Boosted the Price Target from Positive to Hold from $170.00 to $250.00 On 5/7/2021 Morgan Stanley brokerage Lowered the Price Target to Equal Weight from $201.00 to $190.00 On 5/7/2021 The Goldman Sachs Group brokerage Boosted the Price Target to Buy from $206.00 to $228.00 My price target for MRNA is the Fib...
This could be an important area for SRNE right now. You've got Fibs and major moving averages all converging at the same point. News today: "Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a...
VXRT testing another familiar area of "traffic" from the last few months. This 786 fib area has remained a key level on the chart. More times than not, VXRT has failed to break and hold above it for any meaningful amount of time. But thanks to new covid cases and its recent business update, things are popping on Aug 9th. Though the volume isn't anything crazy...
Since Covid-19 is here to stay with us with its variants and the vaccines don`t offer lifetime protection, this means that there is room for other companies to develop a better vaccine to address the problem. And the gains in vaccines stock are quite similar to cryptocurrencies year over year. From all time low to all time high, BNTX made 19X, MRNA 24X and NVAX...
AEMD seems to like this range between the 786 and 618 fib lines. The 618 has long-been a point of resistance on the chart. Meanwhile, the last few days have seen it test the 786 level but hold both above it AND its 50DMA. No news today but focus on biotechs thanks to CYTK earlier could be a sympathy trigger at play. Also with the Delta varient becoming "a...
Took the chart back out to March of last year to do a little fib retracement. Wouldn't you know, CLVS has been channel bound for a minute between the 618 and 786 fib lines with pretty clear support and resistance levels at each. Since it retraced back to the 786 again and is holding (for now), volume is likely going to be the "friend" or "foe" depending on how...
Celsion is at a key support level & may bounce at this point. Potential move to 600 ema? Seeing multiple confluences. Volume is extremely low. Potential news? Keeping an eye on this one. Lot's in the works.
Symbol: NASDAQ:NVAX Top Indicator: Laguerre RSI Bottom Indicator: Tradingview MACD Here is a pattern based off of Fractals. We have a divergence in the MACD and two big trendlines coming into play. We could see a big move either way here, price has been hanging out after a solid move up and the dips are getting bought but we haven't broken out yet.
WITH BIG NEW FROM PRESIDENT BIDEN THIS WEEK SUPPLYING OVER 500 MILLION VACCINES AROUND THE WORLD. PFIZER LOOKS READY FOR ITS NEXT BULL RUN, WITH A PERFECT ENTRY BUY CANDLE ON THE WEEKLY TIMEFRAME. #BLESSEDPIPS
After assessing Sanofi both technically and fundamentally my position on it is a strong buy.
In my work, I always try to combine fundamental analysis and technical analysis. They are both important, especially on a topic as important as the covid vaccine. Johnson & Johnson is about to be marketed, after the approval of the EMA on 11 March. Exactly after the announcement, I bought the stock. The JnJ vaccine has a much lower distribution cost than Pfizer...
On PFIZER , H1 timeframe price is around a critical decision zone, so what can we expect here: 1. Global Recover: If the fundamentals are positive, then the chart will be bullish and we will go into the 1st scenario where price continues to trade inside the channel until it reaches the resistance zone were we can look for sell setups. 2. Failure: Unlike the...
Fundamental and Technical Analysis show this as a very strong buy candidate. I can see this hitting 930.00 within 8 Weeks.
The 55-day moving average broke down, just the 99-day moving average has remained to lift off. with the positive result of the COVID-19 vaccine trial, everything is possible.
VBIV CEO Baxter said on a feb 5 2021 podcast that human trials were to begin in the next couple of weeks for their single dose monovalent covid vaccine vbi-2902, which received $56 Million from Canada to produce a vaccine. Today moderna announced forecasted sales of ~$18 Billion just from covid vaccine sales. Once VBi announces initiation of human trials for the...
MRNA’s short-, long and mid-term trend charts are presented. ___ Prompt: New traders should take some time and carefully read the post entitled 'You can't beat the market' that is located in my profile. Disclaimer The author of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes...